
Director, Lupus Clinic 🦋@ClevelandClinic Associate Professor of Medicine @CCLCM
Cleveland, OH
Joined March 2015
- Tweets362
- Following306
- Followers1.7K
- Likes2.1K
Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial - Annals of the Rheumatic Diseases ard.eular.org/article/S0003-…
115
Very excited to have been a part of this study as it moves into phase 3!
lupus.org/news/fda-grants-fa…
Emily Littlejohn retweeted
NEXT STEPS: Karp and investigators are engaged in the MONA LISA study - Using smile Data and biospeciments – they intend to look for biomarkers that may better predict the future development of SLE Dr. David Karp lecturing at UTSW @drdavidkarp @utswrheum
Emily Littlejohn retweeted
REcently published SMILE study looked at the potential of HCQ (vs PBO) to prevent SLE in at risk people. Had to be ANA+ and 1-2 SLICC criteria at entry. Can you Prevent SLE? Dr. David Karp lecturing at UTSW @drdavidkarp @utswrheum
The "kissing disease" and lupus
Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus | Science Translational Medicine science.org/doi/10.1126/scit…
3
701
To our patients with autoimmune diseases asking about the benefits of GLP-1s; the anti inflammatory effects are beyond those of weight loss alone ⬇️ @CleClinicMD
6
809
Cleveland Clinic work fam @CleClinicMD @CCalabreseDO 🥰
1
12
768
Every 1 mg counts; every 1 mg x 3 = increase in permanent organ damage
STEP: New Steroid Rules for Lupus youtu.be/e11G2nnut8g?si=_Wjy… via @YouTube
1
3
797
Emily Littlejohn retweeted
IMPACT Study - Certolizumab Efficacy in APS Pregnancies
A pilot trial assessed the safety and value of tumour necrosis factor α inhibitor treatment with certolizumab in patients with high-risk pregnancies with antiphospholipid syndrome (APS). Certolizumab (CZP) was shown to reduced the risk of adverse pregnancy outcomes (APOs) in high-risk patients with APS.
buff.ly/2qMUTs5
Emily Littlejohn retweeted
✅ In-depth knowledge of the interpretation of #antinuclear antibody (#ANA) testing is KEY for the diagnosis of #autoimmune diseases such as #Lupus.
Nice talk at #lupus2025 @LupusCongress Toronto by May Choi about the use of ML to profile ANA images 👍
Emily Littlejohn retweeted
Dr M Petri touts the benefits of HCQ- she has caveats: get an OCT at 5 years, if in rare instances the pt develops heart failure, get an endomyocardial biopsy #CCRE25
Emily Littlejohn retweeted
🔍 @ELittlejohnDO looked beyond measures of disease activity for the benefits CAR T-cell therapy can bring to patients with #lupus
Here are the key takeaways from her talk at the recent #BusyClinician symposium 👇
healio.com/news/rheumatology…
Emily Littlejohn retweeted
A myriad of cardiovascular complications in SLE patients . Need for cardiorheumaology @ELittlejohnDO @CCF_IMCHIEFS @CleClinicHVTI @ACCinTouch
Emily Littlejohn retweeted
🗣️ “Every day that goes by we feel more comfortable using the word #remission in #lupus,” Dr. @ELittlejohnDO @ClevelandClinic.
See more from the #BusyClinician special series on CAR-T. ⬇️
bit.ly/4boqYea
Emily Littlejohn retweeted
Join our LIVE GLOBAL TOWN HALL w Georg Schett & @MaxKonigMD - the latest data on the theory and practice of CAR-T Rx for #autoimmunity - registration FREE - 2 hrs & our news letter x 1 yr- Designed for the busy clinician!! @ELittlejohnDO @AdamJBrownMD ccfcme.org/Clinical25





















